3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Lymphoid
1
Genitourinary
1
CNS
1
Conditions
Glioma
3
Wilms Tumor
1
Sarcoma, Synovial
1
Sarcoma, Ewing
1
Sarcoma
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Osteosarcoma
1
Neuroectodermal Tumors, Primitive
1
Neuroblastoma
1
Neoplasms, Neuroepithelial
1
Medulloblastoma
1
Lymphoma, Non-Hodgkin
1
Lymphoma
1
Hodgkin Disease
1
Gliosarcoma
1
Glioblastoma
1
Ependymoma
1
Diffuse Intrinsic Pontine Glioma
1
Desmoplastic Small Round Cell Tumor
1
Interventions
Cyclophosphamide
14
Etoposide
12
Temozolomide
10
Carboplatin
9
Granulocyte Colony-Stimulating Factor
8
Filgrastim
8
Vincristine
7
etoposide phosphate
6
X-Rays
6
Thiotepa
6
Phantoms, Imaging
6
Magnetic Resonance Spectroscopy
6
Cisplatin
6
Topotecan
5
Specimen Handling
5
Radiotherapy
5
Nuclear Medicine Department, Hospital
5
Methotrexate
5
fludarabine
4
Stem Cell Transplantation
4
Peripheral Blood Stem Cell Transplantation
4
Mesna
4
Melphalan
4
Biopsy
4
palbociclib
3
Sirolimus
3
Irinotecan
3
Ifosfamide
3
Busulfan
3
Automobiles
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Rhabdoid Tumor
×
CLR1404
×
CNS
×
Clear all
NCT03478462
2026-03-18
CLOVER-2
Cellectar Biosciences, Inc.
Phase 1
Active not recruiting
30 enrolled